Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab

Roberto Scarpioni, Donato Rigante, Luca Cantarini, Marco Ricardi, Vittorio Albertazzi, Luigi Melfa, Antonio Lazzaro
  • Clinical Rheumatology, February 2014, Springer Science + Business Media
  • DOI: 10.1007/s10067-013-2481-2

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/s10067-013-2481-2

The following have contributed to this page: Luca Cantarini

In partnership with: